Literature DB >> 32030437

[Polyneuropathy in older individuals].

W N Löscher1, B Iglseder2.   

Abstract

The peripheral nervous system is subject to changes during the aging process, e.g., deep tendon reflexes decrease, as proprioception does. In contrast, polyneuropathies have to be distinguished from age-associated changes as independent diseases with etiologies similar to those in younger ages. Incidence of polyneuropathies is reported about 118/100,000, the overall prevalence in the general population is estimated to be about 1% and rises to up to 7% in the elderly. Etiology includes metabolic disorders, primary inflammatory polyneuropathies, systemic disorders and vasculitic neuropathies. Due to the age-specific increase of the prevalence of certain etiologies, neuropathies associated with diabetes, malignancy, and monoclonal gammopathies are even more common in older patients. However, the proportion of cryptogenic neuropathies, e.g. neuropathies without obvious cause, increases also with age. In older age, polyneuropathies additionally impair mobility and increase the risk of falling, thus the assessment of functional abilities is mandatory. It is essential to try to identify the underlying cause by a systematic approach including history, clinical investigation, neurophysiological and lab exams. Treatment of polyneuropathies is based on therapy of underlying conditions and requires management of neuropathic pain in the majority of cases. Physiotherapy and rehabilitation target pain relief and sustaining activities of daily living.

Entities:  

Keywords:  Aging; Diabetic neuropathies; Monoclonal gammopathy of undetermined significance; Peripheral nervous system; Polyneuropathy, axonal, idiopathic, chronic

Mesh:

Year:  2020        PMID: 32030437     DOI: 10.1007/s00108-020-00748-6

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  32 in total

1.  Neuropathy and levodopa in Parkinson's disease: evidence from a multicenter study.

Authors:  Roberto Ceravolo; Giovanni Cossu; Monica Bandettini di Poggio; Lucio Santoro; Paolo Barone; Maurizio Zibetti; Daniela Frosini; Valentina Nicoletti; Fiore Manganelli; Rosa Iodice; Marina Picillo; Aristide Merola; Leonardo Lopiano; Alessandra Paribello; Davide Manca; Maurizio Melis; Roberta Marchese; Paolo Borelli; Alessandra Mereu; Paolo Contu; Giovanni Abbruzzese; Ubaldo Bonuccelli
Journal:  Mov Disord       Date:  2013-07-08       Impact factor: 10.338

Review 2.  Proprioceptive sensibility in the elderly: degeneration, functional consequences and plastic-adaptive processes.

Authors:  Daniel J Goble; James P Coxon; Nicole Wenderoth; Annouchka Van Impe; Stephan P Swinnen
Journal:  Neurosci Biobehav Rev       Date:  2008-08-26       Impact factor: 8.989

Review 3.  Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease.

Authors:  David Adams; Haruki Koike; Michel Slama; Teresa Coelho
Journal:  Nat Rev Neurol       Date:  2019-06-17       Impact factor: 42.937

Review 4.  Lumbosacral plexopathy.

Authors:  P James B Dyck; Pariwat Thaisetthawatkul
Journal:  Continuum (Minneap Minn)       Date:  2014-10

Review 5.  What is dynapenia?

Authors:  Brian C Clark; Todd M Manini
Journal:  Nutrition       Date:  2012-05       Impact factor: 4.008

Review 6.  Paraneoplastic neuropathies.

Authors:  Jean-Christophe Antoine; Jean-Philippe Camdessanché
Journal:  Curr Opin Neurol       Date:  2017-10       Impact factor: 5.710

7.  Longitudinal patient-oriented outcomes in neuropathy: Importance of early detection and falls.

Authors:  Brian Callaghan; Kevin Kerber; Kenneth M Langa; Mousumi Banerjee; Ann Rodgers; Ryan McCammon; James Burke; Eva Feldman
Journal:  Neurology       Date:  2015-05-27       Impact factor: 9.910

8.  Polyneuropathy relates to impairment in daily activities, worse gait, and fall-related injuries.

Authors:  Rens Hanewinckel; Judith Drenthen; Vincentius J A Verlinden; Sirwan K L Darweesh; Jos N van der Geest; Albert Hofman; Pieter A van Doorn; M Arfan Ikram
Journal:  Neurology       Date:  2017-05-31       Impact factor: 9.910

Review 9.  Guideline of transthyretin-related hereditary amyloidosis for clinicians.

Authors:  Yukio Ando; Teresa Coelho; John L Berk; Márcia Waddington Cruz; Bo-Göran Ericzon; Shu-ichi Ikeda; W David Lewis; Laura Obici; Violaine Planté-Bordeneuve; Claudio Rapezzi; Gerard Said; Fabrizio Salvi
Journal:  Orphanet J Rare Dis       Date:  2013-02-20       Impact factor: 4.123

Review 10.  "Red-flag" symptom clusters in transthyretin familial amyloid polyneuropathy.

Authors:  Isabel Conceição; Alejandra González-Duarte; Laura Obici; Hartmut H-J Schmidt; Damien Simoneau; Moh-Lim Ong; Leslie Amass
Journal:  J Peripher Nerv Syst       Date:  2016-03       Impact factor: 3.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.